PharmTech News

Articles

AstraZeneca received conditional marketing authorization for Tagrisso, a tablet for the treatment of adults with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer.

European Commission Grants Conditional Marketing Authorization to AstraZeneca

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

Several biopharmaceutical companies announce plans to launch R&D into Zika vaccine candidates.

Biopharmaceutical Companies Announce Plans to Develop Zika Vaccine

Pfizer and Bristol-Myers Squibb enter into agreement with Portola to develop and commercialize andexanet alfa in Japan.

Pfizer and Bristol-Myers Squibb Enter Into Agreement with Portola

Novartis announced the companies plan to boost growth at Alcon, the company’s vision care division.

Novartis Announces Plans to Accelerate Growth of Vision Care Division

Amgen announces FDA will review the company’s BLA for ABP 501.

FDA Accepts Amgen’s ABP 501 Biosimilar for Review

NICE announces plans to back biosimilar alternatives to Merck’s Remicade.

NICE Announces Plans to Back Remicade Biosimilars

On Jan. 27, 2016 FDA announced it plans to review Merck’s investigational antitoxin prevention bezlotoxumab.

FDA Will Review BLA for Merck’s Bezlotoxumab

Baxter has voluntarily recalled lots of IV solutions due to potential container leakages and particulate matter.

Baxter Recalls IV Solutions

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

The partnership will focus on the identification and analysis of host-cell proteins in biologics.

SCIEX and the Bioprocessing Technology Institute Announce Partnership

Novartis announced on Jan. 5, 2016 that the company is collaborating with Qualcomm to develop cloud-based technology for COPD patients.

Bio/Pharma News